---
document_datetime: 2023-09-21 21:01:23
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/daptomycin-hospira-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: daptomycin-hospira-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.1897857
conversion_datetime: 2025-12-19 11:59:34.400893
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Daptomycin Hospira

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0020              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 25/03/2022                          |                                             | SmPC, Annex II and PL            |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| N/0021      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                     | 01/03/2022   |            | PL                               |                                                                                                                                                                                                                                                                                  |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0019     | B.II.g.5.b - Implementation of changes foreseen in an approved change management protocol - Requires further supporting data                                                                                                                                                                                                                                                                                                                                         | 22/12/2021   | n/a        |                                  |                                                                                                                                                                                                                                                                                  |
| R/0018      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                              | 16/09/2021   | 12/11/2021 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Daptomycin Hospira in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IAIN/0017/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 15/03/2021   | n/a        |                                  |                                                                                                                                                                                                                                                                                  |
| IA/0016     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                        | 05/02/2021   | 12/11/2021 | Annex II and PL                  |                                                                                                                                                                                                                                                                                  |
| II/0014/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of                                                                                                                                                                                                                                                                                                                                                                         | 10/12/2020   | 12/11/2021 | SmPC and PL                      |                                                                                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

| manufacturing sites B.I.a.1.b - Change in the starting material/reagent/intermediate Introduction of a manufacturer by an ASMF B.I.b.1.z - Change in the and/or limits of an AS, material/intermediate/reagent B.I.b.2.e - Change in test starting material/reagent/intermediate changes to a test procedure or addition) for the AS material/intermediate B.II.b.1.z - Replacement manufacturing site for B.II.d.1.e - Change in the and/or limits of the finished outside the approved specifications B.II.d.1.z - Change in the and/or limits of the finished B.II.d.2.d - Change in test product - Other changes (including replacement B.II.e.1.a.3 - Change in finished product - Qualitative composition - Sterile medicinal biological/immunological B.II.g.2 - Introduction management protocol related B.II.b.1.a - Replacement manufacturing site for   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|         | - Change to importer, batch release and quality control testing of the FP - Replacement/addition of a site where batch takes place                                                                                                                                                                                                                                                                                                                             |            |            |                              | B.II.b.2.a arrangements control/testing   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------------|-------------------------------------------|
| IB/0015 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                   | 24/11/2020 | 12/11/2021 | SmPC, Labelling and PL       |                                           |
| IB/0013 | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                  | 18/09/2020 | 12/11/2021 | SmPC, Annex II and Labelling |                                           |
| N/0012  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                               | 02/12/2019 | 12/11/2021 | PL                           |                                           |
|         | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference | 21/08/2019 | 01/10/2019 | SmPC, Annex II and PL        | IB/0011/G                                 |

<div style=\"page-break-after: always\"></div>

|           | the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |            |                        | new additional data   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------|
| N/0010    | Minor change in labelling or package leaflet not the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 09/04/2019 | 01/10/2019 | PL                     | connected with        |
| IAIN/0009 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                              | 20/12/2018 | 01/10/2019 | Annex II and PL        |                       |
| T/0008    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 25/09/2018 | 14/11/2018 | SmPC, Labelling and PL |                       |
| II/0006/G | This was an application for a group of variations. B.II.a.3.b.2 - Changes in the composition (excipients) of the finished product - Other excipients                                                                                                                                                                                                                                                                                                                                                                                | 13/09/2018 | 14/11/2018 | SmPC, Labelling and PL |                       |

<div style=\"page-break-after: always\"></div>

|         | or quantitative changes in one or more excipients that may have a significant impact on the safety, quality or efficacy of the product B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation   |            |            |                        | - Qualitative   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------|
| IB/0007 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 13/04/2018 | 14/11/2018 | SmPC and PL            |                 |
| IB/0005 | C.I.6.b - Change(s) to therapeutic indication(s) - Deletion of a therapeutic indication                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 10/01/2018 | 08/02/2018 | SmPC, Labelling and PL |                 |
| II/0003 | B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 07/12/2017 | n/a        |                        |                 |

<div style=\"page-break-after: always\"></div>

| IB/0001/G   | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall AS   | 23/11/2017   | n/a        |    | quality of the   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|------------------|
| N/0004      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 20/11/2017   | 08/02/2018 | PL |                  |
| IB/0002     | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/08/2017   | n/a        |    |                  |